GE HealthCare (GEHC) was spun out of General Electric (GE) after a tough 2022, a year marred by supply-chain problems and inflation. Investors, though, like what they’ve seen from the company so far in 2023, the inaugural year for the newly independent company, with the stock gaining 26% since its public debut, Al Root writes in this week’s edition of Barron’s. GE HealthCare expects to grow sales at a mid-single-digit annual percentage rate while expanding profit margins to almost 20%. That growth and profit equation could yield earnings per share of more than $6 by mid-decade. If GE HealthCare stock trades in line with the market at that point, shares would be about $110 apiece-a 20% annualized gain, the author notes. Reference Link
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on GE:
- General Electric call volume above normal and directionally bullish
- General Electric price target raised to $100 from $93 at RBC Capital
- General Electric price target raised to $100 from $88 at JPMorgan
- General Electric price target raised to $105 from $96 at BofA
- GE Surges as Aviation Demand Spikes
